Literature DB >> 30451204

Combined central retinal vein occlusion and branch retinal artery occlusion.

Sugandha Goel1, Kumar Saurabh1, Rupak Roy1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30451204      PMCID: PMC6256882          DOI: 10.4103/ijo.IJO_977_18

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
A 66-years-old female was diagnosed to have combined central retinal vein occlusion (CRVO) and branch retinal artery occlusion (BRAO). Colour fundus photograph [Fig. 1a] showing multiple haemorrhages and pale ischaemic area superiorly (black arrow). In Fig. 1b, fundus fluorescein angiography (FFA) shows delayed arterial filling and prolonged arteriovenous transit time. Multicolour imaging highlights the area of ischaemia (black arrow) and serous fluid in macular area as dark green as shown in Fig. 1c. In Fig. 1d and e, optical coherence tomography shows hyper-reflectivity of inner retinal layers (red arrow) and serous detachment (star), respectively.
Figure 1

Colour fundus photograph (a) showing multiple haemorrhages, disc oedema, and pale ischaemic area superiorly (black arrow). Fundus fluorescein angiography (b) showing delayed arterial dye filling and prolonged arteriovenous transit time. Multicolour imaging (c) highlighting the area of ischaemia (black arrow) and showing greenish tinge in the area of macular oedema. Optical coherence tomography showing hyper-reflectivity of inner retinal layers (d) (red arrow) and increase in retinal thickness (e) in the corresponding areas

Colour fundus photograph (a) showing multiple haemorrhages, disc oedema, and pale ischaemic area superiorly (black arrow). Fundus fluorescein angiography (b) showing delayed arterial dye filling and prolonged arteriovenous transit time. Multicolour imaging (c) highlighting the area of ischaemia (black arrow) and showing greenish tinge in the area of macular oedema. Optical coherence tomography showing hyper-reflectivity of inner retinal layers (d) (red arrow) and increase in retinal thickness (e) in the corresponding areas Combined CRVO and BRAO is uncommon and the arterial occlusion is often missed.[12] Echocardiography, carotid Doppler ultrasound, and magnetic resonance imaging brain should be added whenever investigating a combined occlusion.[3]

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  3 in total

Review 1.  Management of Acute Retinal Ischemia: Follow the Guidelines!

Authors:  Valérie Biousse; Fadi Nahab; Nancy J Newman
Journal:  Ophthalmology       Date:  2018-04-30       Impact factor: 12.079

2.  Dexamethasone implant (ozurdex) in a case with unilateral simultaneous central retinal vein and branch retinal artery occlusion.

Authors:  Taylan Ozturk; Omer Takes; A Osman Saatci
Journal:  Case Rep Ophthalmol       Date:  2015-02-23

3.  Detection of underdiagnosed concurrent branch retinal artery occlusion in a patient with central retinal vein occlusion using spectral domain optical coherence tomography.

Authors:  Anushavan Karapetyan; Pingbo Ouyang; Luo Sheng Tang; Jiexi Zeng; Michele Dominique Li Ying
Journal:  BMC Ophthalmol       Date:  2014-07-12       Impact factor: 2.209

  3 in total
  1 in total

Review 1.  Combined retinal vascular occlusion: Demography, clinical features, visual outcome, systemic co-morbidities, and literature review.

Authors:  Vishal Raval; Sameera Nayak; Merlin Saldanha; Subhadra Jalali; Rajeev Reddy Pappuru; Raja Narayanan; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.